Lower risk Drug recall · FDA · Published February 14, 2022

BayCare Central Pharmacy Recalls Norepinephrine IV Solution Due to Subpotent Drug

BayCare Central Pharmacy recalls specific lots of norepinephrine bitartrate 16 mg IV solution (0.9% NaCl) due to subpotent drug. This medication is prescribed only and may not contain enough active ingredient for effective treatment.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0569-2022Drug BayCare Central Pharmacy ›

Lower-risk recall

Subpotent drug

Take action

Contact the company

Recalling firmBayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy7802 E Telecom Pkwy · Temple Terrace, FL 33637-0928

✎ GovInfoNow plain-language explainer

BayCare Central Pharmacy has recalled specific lots of norepinephrine bitartrate 16 mg IV solution (0.9% NaCl) because the medication may be subpotent. This means the solution might not contain enough active drug to treat patients effectively, which could lead to inadequate medical treatment. Read more at govinfonow.com/recall/35224-baycare-central-pharmacy-recalls-norepinephrine-iv-solution-due-to-subpotent.

Source Summary by GovInfoNow · govinfonow.com/recall/35224-baycare-central-pharmacy-recalls-norepinephrine-iv-solution-due-to-subpotent · Updated August 18, 2026 · FDA enforcement record: FDA #D-0569-2022

Cite this page

“BayCare Central Pharmacy Recalls Norepinephrine IV Solution Due to Subpotent Drug.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35224-baycare-central-pharmacy-recalls-norepinephrine-iv-solution-due-to-subpotent. Based on FDA recall #D-0569-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0569-2022%22&limit=1).

The FDA announced on Feb. 14, 2022, that BayCare Central Pharmacy recalled Norepinephrine bitartrate IV bags due to subpotency risks. The voluntary Class III recall affects 1,157 units distributed in Florida.

How to tell if you have it

Brand: BayCare Central Pharmacy
Product: Norepinephrine bitartrate 16 mg in 250 mL NaCl 0.9% IV bags
Lot codes: Nore1620220111, Nore1620220113, Nore1620220118, Nore1620220125, Nore1620220127, Nore1620220202
Expiration: 3/31/22
Quantity: 1,157 bags

The hazard

The recalled product is a subpotent drug. The FDA classified the recall as Class III.

Context

GovInfoNow's records show BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy has two other recalls on record since July 30, 2021. On Dec. 1, 2022, the pharmacy recalled Iohexol Syringes due to labeling errors that risked incorrect dosing. Other recent recalls of similar products include IntegraDose Vasopressin 2 Units/2mL Recall (May 18, 2026), Unichem busPIRone 5mg Tablets Recall (April 13, 2026), and Specialty Process Labs Thyroid Product Recall (Jan. 16, 2026).

How to tell if you have this one

Check for the lot numbers: Nore1620220111, Nore1620220113, Nore1620220118, Nore1620220125, Nore1620220127, Nore1620220202. The product is a prescription-only IV solution sold by BayCare Central Pharmacy in Temple Terrace, Florida.

Brand
BayCare Central Pharmacy
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Product Lot Number
Look for the lot numbers Nore1620220111, Nore1620220113, Nore1620220118, Nore1620220125, Nore1620220127, or Nore1620220202 on the IV bag.

Where it went and when

Where it was distributed

Distributed in Florida.

FDA distribution: “Florida” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Florida.

Recall timeline

FDA terminated this recall 10 months after the firm started it.

Feb 14, 2022Firm started the recall
Feb 18, 2022FDA classified it Class III
Mar 2, 2022Published in FDA’s Enforcement Report
Dec 8, 2022FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

From the GovInfoNow team · based on the FDA notice · How we make summaries

What should I do if I have this medication?

Contact BayCare Central Pharmacy at (813) 901-6392 to confirm if your lot number is recalled and get instructions.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/35224-baycare-central-pharmacy-recalls-norepinephrine-iv-solution-due-to-subpotent">BayCare Central Pharmacy Recalls Norepinephrine IV Solution Due to Subpotent Drug (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0569-2022 (February 14, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0569-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.